Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06567236 · ClinicalTrials.gov registry record · NA
E4D Compare Adapted to Preclinical Endodontics
A NA study of Self-Perception and Self-Assessment, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT06567236: Completed NA study of Self-Perception and Self-Assessment, sponsored by Texas A&M University.
NCT06567236 is a NA study of Self-Perception and Self-Assessment that has completed, run by Texas A&M University. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06567236, a NA study of Self-Perception and Self-Assessment, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
Based on pilot study's promising results, we decided to further investigate the impact of adapting Planmeca Romexis Compare software to evaluate pulpal access preparations on second-year dental students' technical performance, self-evaluation skills and opinions. No educational records, grades, coursework, or any other assignments that are completed as part of the regular class will be analyzed as part of this study.
Primary Outcome
Compare self-assessment after traditional method only and with extra 3D software method
Conditions Studied
Interventions
- OTHER 3D software
Study Locations (1)
Texas
- Texas A&M School of Dentistry - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2023-05-08 |
| Phase | NA |
What the finished NCT06567236 record still lists
NCT06567236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Self-Perception appearing as the primary indexed condition, and to 1 intervention - of which 3D software is the first listed.
NCT06567236 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06567236 about?
NCT06567236 is a clinical study titled "E4D Compare Adapted to Preclinical Endodontics". Based on pilot study's promising results, we decided to further investigate the impact of adapting Planmeca Romexis Compare software to evaluate pulpal access preparations on second-year dental students' technical performance, self-evaluation skills and opinions. No educational records, grades, cour...
What is the current status of trial NCT06567236?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2023-02-27. Estimated completion is 2023-05-08.
What conditions does trial NCT06567236 study?
This clinical trial studies the following conditions: Self-Perception, Self-Assessment.
What interventions are being tested in trial NCT06567236?
The interventions under investigation include: 3D software (OTHER).
Who is sponsoring clinical trial NCT06567236?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06567236 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Self-Perception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06567236's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI